ChromaDex (CDXC) Tops Q3 EPS by 1c
Get Alerts CDXC Hot Sheet
Join SI Premium – FREE
ChromaDex (NASDAQ: CDXC) reported Q3 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $25.6 million versus the consensus estimate of $24.03 million.
For earnings history and earnings-related data on ChromaDex (CDXC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alnylam Pharma (ALNY) reported Q3 result ; Offers Guidance
- H2O America launches $325 million equity units public offering
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share